DBV Technologies | DBVT - 税引前利益





税引前利益 変化する 日付
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amarin USD -852K 7.26M 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
DBV Technologies USD -47.4M 14.24M 2026-03
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Incyte USD 751.51M 407.91M 2026-06
Insmed USD -11.37M 150.72M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
United Therapeutics USD 372.7M 54.4M 2026-06